Neurocognitive Disorders: Clinical Trials

504 trials for Neurocognitive Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

265 completed, 94 unknown, 39 terminated, 38 recruiting. 504 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4504Completed 265, Unknown 94, Terminated 39, Recruiting 38, Not yet recruiting 26, Withdrawn 21, Active not recruiting 13, Enrolling by invitation 7, Suspended 1

Follow Neurocognitive Disorders: new trials by email Literature Review of Neurocognitive Disorders trials Research Report on Neurocognitive Disorders

Trials (filtered) newest first · largest first

All 504 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone, Quetiapine, Placebo - Delirium, Morality
Phase 4WithdrawnUniversity of Southern California2028-03-012026-05-04
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
Donanemab - Alzheimer Disease
Phase 4Not yet recruitingEli Lilly and Company502026-11-012026-10-15
Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery
Remimazolam Besylate, propofol - Aortic Aneurysm of the Proximal Arch, Aortic Aneurysms Arch
Phase 4Not yet recruitingSeoul National University Hospital802026-10-012026-09-17
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Rosuvastatin, Ezetimibe, Recaticimab - Intracranial Arteriosclerosis, Cognitive Impairment
Phase 4Not yet recruitingPeking Union Medical College Hospital4402026-09-172026-09-15
Remifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality
Opioids - Emergence Delirium, Emergence Agitation
Phase 4Not yet recruitingKonya City Hospital882026-09-052026-10-06
Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
Low dose ketamine infusion, Dexmedetomidine infusion - Delirium in Intensive Care Unit, Acute Heart Failure (AHF)
Phase 4Not yet recruitingAlexandria University1502026-09-012026-08-24
Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients
Lemborexant, Placebo - Sleep Disturbance, Delirium
Phase 4RecruitingMahidol University1002026-09-012026-10-08
Comparing the Efficacy of Propofol and Dexmedetomidine in Prevention of Emergence Agitation After Sevoflurane Anesthesia in Children
propofol 1mg/kg, Dexmedetomidine - Emergence Delirium, Anesthesia
Phase 4RecruitingPakistan Institute of Medical Sciences1142026-08-282026-09-02
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Donanemab, Placebo - Down Syndrome (DS), Down Syndrome (Trisomy 21)
Phase 4Not yet recruitingMichael Rafii, MD, PhD602026-08-012026-05-15
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery
Remimazolam - Emergence Agitation, General Anesthesia
Phase 4Not yet recruitingJeju National University School of Medicine1382026-07-242026-07-31
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
Lecanemab - Alzheimer Disease
Phase 4RecruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine1002026-07-102026-07-07
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Acoramidis (AG10) oral tablet - Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis
Phase 4RecruitingEidos Therapeutics, a BridgeBio company1502026-07-012026-07-29
Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
Dexmedetomidine (IV) 0.5 mcg/kg, Propofol (IV) 2-4 mg/kg, Dexmedetomidine (IV) 1 mcg/kg - MRI Sedation, Pediatric Sedation
Phase 4RecruitingBoston Children's Hospital1052026-06-302026-09-21
Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment
Ginkgo Biloba Extract 240 mg, Placebo - Mild Cognitive Impairment, Alzheimer's Disease
Phase 4Not yet recruitingHanyang University1202026-06-012026-06-26
Light and Sleep Fragmentation
Light therapy - Sleep, Mild Cognitive Impairment
Phase 4Not yet recruitingStanford University1202026-06-012023-08-25
Effect of Ciprofol Injection on Postoperative Cognitive Function
Ciprofol group, Propofol group - Postoperative Cognitive Dysfunction
Phase 4Active not recruitingThe Second Affiliated Hospital of Chongqing Medical University2982026-06-012026-06-29
Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children
Dexmedetomidine, Esketamine, Normal Saline - Behavior Problem
Phase 4Not yet recruitingNanjing Children's Hospital3422026-06-012026-05-06
Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment
Dexmedetomidine-esketamine combination, Placebo - Older Adults, Cognitive Impairment
Phase 4Not yet recruitingPeking University First Hospital602026-06-012026-06-01
Dexmedetomidine Nasal Spray on Postoperative Delirium in Elderly Thoracoscopic Lung Resection Patients
Dexmedetomidine hydrochloride nasal spray, Placebo - Postoperative Delirium (POD)
Phase 4Not yet recruitingSichuan Provincial People's Hospital2642026-06-012026-05-12
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Zunveyl® - Alzheimer Disease
Phase 4RecruitingAlpha Cognition, Inc1502026-05-202026-10-19

Showing 20 of 504. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (136)  ·  Cognitive Dysfunction (127)  ·  Emergence Delirium (93)  ·  Delirium (91)  ·  Dementia (73)  ·  Cognition Disorders (29)  ·  Postoperative Cognitive Complications (26)  ·  Depression (23)  ·  Schizophrenia (16)  ·  Psychomotor Agitation (14)  ·  Stroke (14)  ·  Lewy Body Disease (12)  ·  Psychotic Disorders (12)  ·  Parkinson Disease (10)  ·  Depressive Disorder, Major (9)

Broader conditions

Mental Disorders (495)  ·  Nervous System Diseases (408)  ·  Pathological Conditions, Signs and Symptoms (256)  ·  Central Nervous System Diseases (225)  ·  Brain Diseases (223)  ·  Signs and Symptoms (222)  ·  Neurologic Manifestations (217)  ·  Neurobehavioral Manifestations (204)  ·  Confusion (170)  ·  Neurodegenerative Diseases (163)  ·  Cognition Disorders (150)  ·  Pathologic Processes (141)  ·  Tauopathies (137)  ·  Dementia (126)

Interventions

Dexmedetomidine (68)  ·  Propofol (41)  ·  Donepezil (36)  ·  Saline Solution (36)  ·  Memantine (32)  ·  Sevoflurane (21)  ·  Sodium Chloride (21)  ·  Midazolam (19)  ·  Rivastigmine (18)  ·  Ketamine (15)  ·  Galantamine (12)  ·  Escitalopram (11)  ·  Risperidone (10)  ·  Fentanyl (9)  ·  Haloperidol (9)

Sponsors

Peking University First Hospital (15)  ·  Mayo Clinic (8)  ·  Novartis (8)  ·  Novartis Pharmaceuticals (8)  ·  University of California, Los Angeles (8)  ·  Eisai Inc. (7)  ·  NYU Langone Health (6)  ·  New York State Psychiatric Institute (6)  ·  VA Office of Research and Development (6)  ·  Sunnybrook Health Sciences Centre (5)  ·  University Hospital, Basel, Switzerland (5)  ·  University of Pennsylvania (5)  ·  Assiut University (4)  ·  Avid Radiopharmaceuticals (4)  ·  Chinese PLA General Hospital (4)

Countries

United States (168)  ·  China (87)  ·  South Korea (31)  ·  Egypt (17)  ·  Canada (15)  ·  Germany (12)  ·  Turkey (Türkiye) (11)  ·  Italy (10)  ·  France (9)  ·  Spain (9)  ·  Denmark (8)  ·  Netherlands (8)  ·  Switzerland (8)  ·  United Kingdom (8)  ·  Norway (6)

Top investigators

Dong-Xin Wang, MD, PhD (10)  ·  Davangere Devanand, M.D. (3)  ·  Helen Lavretsky, M.D. (3)  ·  Alexa Hollinger, MD (2)  ·  Anita Murthy (2)  ·  Bradley Boeve, MD (2)  ·  E. Sherwood Brown, MD, PhD (2)  ·  Jeff Silverstein, MD (2)  ·  Jian-Xin Zhou, MD (2)  ·  Jihee Mun (2)  ·  Jinzhou Tian, M.D,PhD (2)

Results publications

PMID 33189083, PMID 12760985, PMID 15114210, PMID 19617584, PMID 35833913, PMID 36413436, PMID 37142273, PMID 39498781, PMID 10070549, PMID 10511011, PMID 10588403, PMID 10913502, PMID 11065205, PMID 11072948, PMID 1130742, PMID 11903027, PMID 12075033, PMID 12556542, PMID 12640407, PMID 12648190, PMID 1394752, PMID 14595310, PMID 15082703, PMID 15374380, PMID 15817019, PMID 1593914, PMID 16469995, PMID 16494088, PMID 16677266, PMID 17060562, PMID 17179249, PMID 17183151, PMID 17325517, PMID 17667565, PMID 17914039, PMID 17986678, PMID 18198262, PMID 18251622, PMID 18372935, PMID 18591575, PMID 18611150, PMID 18813051, PMID 19210951, PMID 19253247, PMID 19347026, PMID 19389332, PMID 19422355, PMID 19687169, PMID 19812461, PMID 19865006

NIH funding

2005 (2), 2014 (2), 2017 (2), 2025 (2), 2004 (1), 2008 (1), 2009 (1), 2015 (1), 2019 (1), I01RX003143 (1), I21RX002180 (1), K23AA017666 (1), P30AG028747 (1), P30AI045008 (1), P50AG016574 (1)